TB-500 + BPC-157 Subcutaneous Injection Pen - Inject+

Australia's First
TB-500 & BPC-157
Subcutaneous Pen



What is TB-500 and BPC-157?

BPC-157 and TB-500 are two laboratory-synthesised peptides under active investigation for their potential roles in tissue repair, inflammation control, and systemic regeneration.

While each compound acts through distinct cellular pathways, together they form a complementary pairing frequently explored in integrative and regenerative medicine contexts for their combined influence on healing biology.

BPC-157 (Body Protection Compound-157) originates from a sequence of a naturally occurring gastric protein involved in mucosal protection and angiogenesis.

TB-500 (Thymosin β-4 fragment) is a synthetic section of the thymosin β-4 protein, which regulates actin formation and cell migration critical to wound and tissue recovery.

Both are prescription-only in Australia and supplied as sterile compounded preparations following consultation with a registered clinician.

What BPC-157 and TB-500 Are Being Studied For?

Current research spans molecular, animal, and early human models. Investigations explore both individual and synergistic applications in:

BPC-157
Endothelial protection & angiogenesis: May stimulate VEGF-mediated blood-vessel growth and micro-circulatory stability.
Cytokine modulation: Studied for down-regulating inflammatory messengers such as TNF-α, IL-1β, and IL-6.
Fibroblast activity & collagen organisation: Supports cell migration and alignment during tissue remodelling.
Neuro-gastrointestinal axis: Examined for maintaining mucosal integrity and gut–brain communication balance.

TB-500
Actin polymerisation: Facilitates the assembly of actin filaments, enabling rapid cell movement and structural repair.
Tissue elasticity & regeneration: Investigated in tendon, ligament, and dermal models for recovery potential.
Angiogenic response: May up-regulate VEGF and improve oxygen diffusion to recovering tissue.
Inflammatory regulation: Studied for dampening NF-κB-related pathways and oxidative stress.

COMBINED USE
When evaluated together, the peptides appear to complement and extend each other’s mechanisms, producing potentially broader biological effects:
Enhanced connective-tissue integrity and coordinated collagen repair.
Improved vascular perfusion and oxygen delivery to recovering sites.
Potential cytokine balance and reduced systemic inflammation.
Support for multi-system recovery, not limited to a single tissue type.

All findings remain investigational. Neither compound has received TGA approval for the treatment, prevention, or cure of any condition.

How It's Dispensed?

When prescribed, the BPC-157 + TB-500 formulation is compounded by an Australian-registered pharmacy and dispensed under pharmacist supervision.

Concentration: BPC-157 (2 mg/mL) + TB-500 (3 mg/mL)
Volume: 3 mL pre-filled subcutaneous pen
Preservative system: Formulated in accordance with pharmacy sterility and stability standards
Temperature control: Shipped in insulated packaging with cold packs to maintain integrity during transport

Storage & Handling

Keep refrigerated as directed by the dispensing pharmacy.
Do not freeze or expose to excessive heat.
If ice packs melt during transit, product integrity remains unaffected within the advised shipping window.
Always follow the storage and handling guidance supplied with your prescription.

Usage & Administration

Administration technique, dose volume, and frequency are determined individually by the prescribing clinician.

Follow all instructions printed on the pharmacy label. Do not self-administer unless you have received appropriate training and clinical clearance.

Typical practitioner-directed use may include:
Route: Subcutaneous injection via pre-filled TB-500 + BPC-157 pen.
Injection site: Commonly administered into the lower abdomen or outer thigh for systemic distribution, unless a different strategy is advised.
Pattern: Systemic micro-dosing aimed at supporting connective tissue, soft-tissue recovery and broader repair signalling rather than a single focal point.
Cycle: Frequently structured as five days on and two days off to align with TB-500’s pharmacokinetics and allow periodic receptor reset while maintaining ongoing peptide exposure.
Technique: Clean the skin with an alcohol swab, inject as directed, and dispose of the needle safely after each dose.
Rotation: Alternate injection locations (left/right abdomen or thighs) to reduce irritation and support consistent absorption.

All dosing parameters (including total weekly exposure, cycle length, and overall course duration) are determined by the prescribing clinician according to recovery goals, training load, and individual tolerance.

Safety & Precautions

Schedule 4 (Prescription-Only Medicines) must be prescribed and supervised by a registered healthcare professional.
Disclose all medical conditions, allergies, and concurrent medications before treatment.
Not recommended during pregnancy or breastfeeding unless specifically approved by a clinician.
Report any irritation or unexpected response to your prescriber or pharmacist.
Always store and administer as directed by the dispensing pharmacy.

Research Context

BPC-157 and TB-500 remain areas of active inquiry within regenerative and integrative medicine.

Pre-clinical data suggest roles in endothelial repair, fibroblast activation, and inflammatory regulation; however, evidence in large-scale human trials is limited. Further research is required to establish validated clinical protocols, dosing ranges, and long-term safety profiles. All prescribing in Australia occurs under compounded, off-label frameworks within appropriate medical oversight.

Disclaimer

Educational content only; not medical advice.

BPC-157 and TB-500 compounded preparations are not registered with the Therapeutic Goods Administration (TGA).

No claims of efficacy or therapeutic outcome are made.

All use requires individual consultation and prescription by a registered clinician.
Buy Now, Pay Later with
Earn Points while you Drip with
           

Mobile IV Drip

NAD+ Subcutaneous Pen

NAD+ Subcutaneous injection

NAD+ Infusion

Melbourne NAD+

Brisbane NAD+

Gold Coast NAD+

NAD+ at Home

NAD+

PT-141

Sydney NAD+

NAD+ Injection

NAD+ Australia

BPC-157

Bio-hacking NAD+

anti-aging NAD+

nad+ Injection

Mobile IV drip NAD+

Mobile IV drip NAD+ Melbourne

Mobile IV drip NAD+ Brisbane

Mobile IV drip NAD+ Sydney

Mobile IV drip NAD+ Gold Coast

NAD+ drip at home Melbourne

At home nad+

IV nad

Hydration drip

NAD drip

NAD infusion

IV NAD infusion

NAD drip mobile

NAD IV drip

NAD IV

nad at home

ExclusIV Disclaimer

By continuing, you acknowledge and agree to the following terms and conditions of ExclusIV by Mobile IV Drip:

1. Elective Wellness Services
All IV infusions and subcutaneous products offered through Mobile IV Drip are elective wellness services. They are not prescribed or promoted as medically necessary treatments and are designed to support general wellness and vitality.

2. No Public Advertising
The information displayed in this section is provided privately on request and does not constitute public advertising.

3. No Medical or Therapeutic Claims
No statements here should be interpreted as claims of therapeutic benefit. Services and compounded formulations are not a substitute for professional medical advice, prescribed medication, or conventional treatment.

4. Practitioner Review Required
Before any compounded or prescription-only product is supplied, clients are required to complete medical intake and be reviewed by an authorised prescriber and/or nurse practitioner, and obtain a prescription where required.

5. Pricing
Pricing shown is indicative only and may change following clinical assessment, prescription requirements, or compounding variables. Final costs are confirmed after prescriber approval.

6. Voluntary Request
You confirm you are voluntarily requesting this information for personal education, and that access does not guarantee suitability for every option listed.

7. Privacy
Any information you provide may be used to communicate about consultations, prescriptions or updates, with opt-out available.

By selecting “I want ExclusIV access”, you confirm you have read and understood the above.